Arterial Hypertension, Chronic Obstructive Pulmonary Disease (COPD, Diabetes Mellitus
Conditions
Brief summary
The ANM is the first initiative that puts advanced pharmaceutical care into practice in Andalusia (Spain). The aim of this is study is to evaluate the effectiveness of the intervention Assistance to New Medicines (ANM) in the improvement of adherence to treatment in community pharmacies.
Detailed description
Design: parallel cluster pragmatic randomized controlled trial. The study includes patients users of a community pharmacies, who meet the following inclusion criteria: patient who starts treatment of any of the following pathologies: Chronic Obstructive Pulmonary Disease (COPD), Arterial Hypertension or Diabetes Mellitus in Andalusia (Spain). In order to avoid possible contamination between patients assigned to the control and intervention group, randomization will be carried out at the pharmacy level; preventing the pharmacist from applying part of the intervention to the control group. Interventions: patients randomized: (i) current practice; or (ii) ANM intervention thru a pharmacist delivered support for a newly prescribed medicine.
Interventions
OTHERANM
communication intervention
OTHERPlacebo
regular assistance in community pharmacies
Sponsors
Andalusian School of Public Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Masking description
The statistical analysis will be performed by a person who would be blinded to which arm were assigned the subjects.
Intervention model description
cluster randomized controlled trial.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
patient who starts treatment of any of the following diseases: * Chronic Obstructive Pulmonary Disease (COPD). * Arterial Hypertension * Diabetes Mellitus. * Anticoagulants
Exclusion criteria
* those users who do not know how to read and write in Spanish, * Suffer from a physical or mental disorder that makes it impossible to perform the
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence to treatment | Ten weeks | adherence to treatment may be defined as the extent to which the patient's history of therapeutic drug-taking coincides with the prescribed treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Satisfaction with the service | Ten weeks and six months | The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial. The satisfaction with the service, will be collected thru a likert question (1 not satisfied, 10 very satisfied). |
Countries
Spain
Contacts
Primary ContactAntonio Olry de Labry Lima, PhD
Backup ContactJulia gomez
Outcome results
None listed